{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Apoptosis", "Cell cycle", "Cell migration", "Cytotoxicity", "Leukemia", "Microtubules", "Vitamin K3 derivatives"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "31254176", "DateCompleted": {"Year": "2021", "Month": "06", "Day": "01"}, "DateRevised": {"Year": "2021", "Month": "06", "Day": "01"}, "Article": {"ArticleDate": [{"Year": "2019", "Month": "06", "Day": "29"}], "Language": ["eng"], "ELocationID": ["10.1007/s10637-019-00810-7"], "Journal": {"ISSN": "1573-0646", "JournalIssue": {"Volume": "38", "Issue": "3", "PubDate": {"Year": "2020", "Month": "Jun"}}, "Title": "Investigational new drugs", "ISOAbbreviation": "Invest New Drugs"}, "ArticleTitle": "Vitamin K<sub>3</sub> thio-derivative: a novel specific apoptotic inducer in the doxorubicin-sensitive and -resistant cancer cells.", "Pagination": {"StartPage": "650", "EndPage": "661", "MedlinePgn": "650-661"}, "Abstract": {"AbstractText": ["Vitamin K<sub>3</sub>, also known as menadione, is a synthetic lipid-soluble 2-methyl-1,4- naphthoquinone analogs of vitamin K. The vitamin K derivatives exhibit potent cytotoxicity against several cancer cell lines through ROS induction and mitochondrial dysfunction. We investigated vitamin K<sub>3</sub>-inspired derivatives as potential apoptotic inducers and analyzed their mechanisms beyond apoptosis. The cytotoxicity of a panel of vitamin K<sub>3</sub> analogs was screened against 10 doxorubicin-sensitive and -resistant cancer cell lines overexpressing ATP-binding cassette transporters (P-glycoprotein, ABCB5, BCRP) or oncogenes (\u0394EGFR) or with knockout of tumor suppressors (p53), Cell cycle arrest, apoptosis, cell migration, and microtubule formation were further investigated. The online tool SwissTargetPrediction was utilized for target prediction. Among the screened compounds, one vitamin K<sub>3</sub> thio-derivative (No. 45, VKT-1) exhibited the most potent cytotoxicity specifically against both drug-sensitive and -resistant cancer cell lines. In addition, VKT-1 arrested the cells at the G2/M phase and induced apoptosis as detected by flow cytometry. As predicted by SwissTargetPrediction, VKT-1 targeted microtubule-associated tau protein. Indeed, VKT-1 dramatically inhibited cell migration and microtubule formation in vitro. In conclusion, the synthetic vitamin K<sub>3</sub> thio-derivative (VKT-1) inhibited doxorubicin-sensitive and -resistant tumor cells by cell arrest, apoptosis induction, as well as, migration inhibition, and microtubule deterioration of U2OS-GFP-\u03b1-tubulin cells."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Biology, Institute of Pharmacy and Biochemistry, Johannes Gutenberg University, Staudingerweg 5, 55128, Mainz, Germany."}, {"Identifier": [], "Affiliation": "Chemistry of Medicinal Plants Department, National Research Centre, 33 El-Bohouth St., Dokki, Giza, 12622, Egypt."}], "LastName": "Hegazy", "ForeName": "Mohamed-Elamir F", "Initials": "MF"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Biological Chemistry, Washington State University, Pullman, WA, 99164-6340, USA."}], "LastName": "Fukaya", "ForeName": "Masashi", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Biology, Institute of Pharmacy and Biochemistry, Johannes Gutenberg University, Staudingerweg 5, 55128, Mainz, Germany."}], "LastName": "Dawood", "ForeName": "Mona", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Biology, Institute of Pharmacy and Biochemistry, Johannes Gutenberg University, Staudingerweg 5, 55128, Mainz, Germany."}], "LastName": "Yan", "ForeName": "Ge", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "MicroCombiChem GmbH, Wiesbaden, Germany."}], "LastName": "Klinger", "ForeName": "Anette", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "MicroCombiChem GmbH, Wiesbaden, Germany."}], "LastName": "Fleischer", "ForeName": "Edmond", "Initials": "E"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Animal Wealth Development, Faculty of Veterinary Medicine, Zagazig University, El-Zeraa str. 114, Zagazig, 44511, Egypt."}], "LastName": "Zaglool", "ForeName": "Asmaa W", "Initials": "AW"}, {"Identifier": ["0000-0002-2637-1681"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Biology, Institute of Pharmacy and Biochemistry, Johannes Gutenberg University, Staudingerweg 5, 55128, Mainz, Germany. efferth@uni-mainz.de."}], "LastName": "Efferth", "ForeName": "Thomas", "Initials": "T"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Invest New Drugs", "NlmUniqueID": "8309330", "ISSNLinking": "0167-6997"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "ATP-Binding Cassette Transporters"}, {"RegistryNumber": "0", "NameOfSubstance": "Tubulin"}, {"RegistryNumber": "723JX6CXY5", "NameOfSubstance": "Vitamin K 3"}, {"RegistryNumber": "80168379AG", "NameOfSubstance": "Doxorubicin"}], "MeshHeadingList": [{"QualifierName": ["metabolism"], "DescriptorName": "ATP-Binding Cassette Transporters"}, {"QualifierName": ["drug effects"], "DescriptorName": "Apoptosis"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Cycle Checkpoints"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Division"}, {"QualifierName": [], "DescriptorName": "Cell Line"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Movement"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Doxorubicin"}, {"QualifierName": ["drug effects"], "DescriptorName": "Drug Resistance, Neoplasm"}, {"QualifierName": ["drug effects"], "DescriptorName": "G2 Phase"}, {"QualifierName": [], "DescriptorName": "HEK293 Cells"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["drug effects"], "DescriptorName": "Microtubules"}, {"QualifierName": ["metabolism"], "DescriptorName": "Tubulin"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Vitamin K 3"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2019", "Month": "5", "Day": "1"}, {"Year": "2019", "Month": "6", "Day": "5"}, {"Year": "2019", "Month": "6", "Day": "30", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "6", "Day": "2", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "6", "Day": "30", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["31254176", "10.1007/s10637-019-00810-7", "10.1007/s10637-019-00810-7"]}}]}